Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Nov 26, 2019 8:00 am EST

OPKO Health to Participate in the 31st Annual Piper Jaffray Healthcare Conference

Nov 15, 2019 8:00 am EST

Novitas Issues Final Local Coverage Determination for the 4Kscore® Test

Nov 5, 2019 4:05 pm EST

OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results

Nov 1, 2019 8:00 am EDT

OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019

Oct 24, 2019 6:57 pm EDT

OPKO Health, Inc. Announces Pricing of its Offering of Common Stock

Oct 22, 2019 4:05 pm EDT

OPKO Health, Inc. Announces Proposed Offering of Common Stock

Oct 21, 2019 8:00 am EDT

OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency

Aug 29, 2019 9:24 am EDT

OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency

Aug 7, 2019 4:05 pm EDT

OPKO Health Reports 2019 Second Quarter Business Highlights and Financial Results

Aug 1, 2019 8:00 am EDT

OPKO Health to Report Second Quarter 2019 Financial Results on August 7, 2019